10 Most Undervalued Low Volatility Stocks to Buy Now

8. Bristol-Myers Squibb Company (NYSE:BMY)

Forward P/E: 7.23

Beta: 0.37

Number of Hedge Fund Holders: 67

Bristol-Myers Squibb Company (NYSE:BMY) is one of the top most undervalued low volatility stocks to buy now. On August 25, BMO Capital analyst Evan Seigerman of BMO Capital maintained a Hold rating on Bristol-Myers Squibb Company (NYSE:BMY), retaining the price target of $47.00.

The analyst supported the rating with the present performance and future expectations for Bristol-Myers Squibb Company’s (NYSE:BMY) product, Cobenfy.

Seigerman stated that the drug exhibited solid prescription growth, but the rate did not point to a considerable market breakthrough. The analyst expects the numbers to fall short of the consensus revenue expectations for fiscal Q3 2025 despite a rise in the weekly and monthly prescriptions.

Seigerman added that the revised assumptions regarding inventory levels and gross-to-net discounts add increased uncertainty to revenue forecasts, supporting the Hold rating.

Bristol-Myers Squibb Company (NYSE:BMY) is a biopharmaceutical company that discovers, develops, and delivers advanced medicines for serious diseases. Its medicines fall into various therapeutic classes, including hematology, oncology, cardiovascular, immunology, and neuroscience.